Reducing hippocampal extracellular matrix reverses early memory deficits in a mouse model of Alzheimer’s disease-Reference-Cited by-同舟云学术

Reducing hippocampal extracellular matrix reverses early memory deficits in a mouse model of Alzheimer’s disease

Published:2014-06-29 Issue:1 Volume:2 Page:
ISSN:2051-5960
Container-title:Acta Neuropathologica Communications
language:en
Short-container-title:acta neuropathol commun

Author:

Végh Marlene J,Heldring Céline M,Kamphuis Willem,Hijazi Sara,Timmerman Arie J,Li Ka Wan,van Nierop Pim,Mansvelder Huibert D,Hol Elly M,Smit August B,van Kesteren Ronald E

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Neurology (clinical),Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1186/s40478-014-0076-z.pdf

Reference67 articles.

1. Querfurth HW, LaFerla FM: Alzheimer's disease. New Engl J Med 2010, 362: 329–344.

2. Hardy JA, Higgins GA: Alzheimer's disease: the amyloid cascade hypothesis. Science 1992, 256: 184–185.

3. Karran E, Mercken M, De Strooper B: The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov 2011, 10: 698–712.

4. Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ, Castellani RJ, Crain BJ, Davies P, Del Tredici K, Duyckaerts C, Frosch MP, Haroutunian V, Hof PR, Hulette CM, Hyman BT, Iwatsubo T, Jellinger KA, Jicha GA, Kovari E, Kukull WA, Leverenz JB, Love S, Mackenzie IR, Mann DM, Masliah E, McKee AC, Montine TJ, Morris JC, Schneider JA, et al.: Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol 2012, 71: 362–381.

5. Frisoni GB, Fox NC, Jack CR Jr, Scheltens P, Thompson PM: The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol 2010, 6: 67–77.

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of colony-stimulating factor 1 receptor improves synaptic plasticity and cognitive performance in aged mice;2024-09-03

2. Cerebroprotein hydrolysate-I ameliorates cognitive dysfunction in APP/PS1 mice by inhibiting ferroptosis via the p53/SAT1/ALOX15 signalling pathway;European Journal of Pharmacology;2024-09

3. Edaravone Dexborneol ameliorates the cognitive deficits of APP/PS1 mice by inhibiting TLR4/MAPK signaling pathway via upregulating TREM2;Neuropharmacology;2024-09

4. Bibliometric Analysis of Alzheimer's Disease and Depression;Current Neuropharmacology;2024-07-31

5. Decreased extrasynaptic δ‐GABA_A receptors in PNN‐associated parvalbumin interneurons correlates with anxiety in APP and tau mouse models of Alzheimer's disease;British Journal of Pharmacology;2024-06-17